Metformin does not improve survival in unselected patients with metastatic hormone-sensitive prostate cancer (mHSPC), but the drug may improve survival and other outcomes in those with high-volume ...

Dupilumab significantly reduced severe asthma exacerbations and SCS prescriptions vs omalizumab in patients using add-on maintenance therapy.

According to the FDA, Apple’s Sleep Apnea Notification Feature is not intended to diagnose, treat, or aid in the management of sleep apnea.

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

In the middle-aged population studied, 32% of those with CAL, 18% of those with emphysema, and 31% of those with impaired DLCO had never smoked. Impaired diffusing capacity for carbon monoxide (DLCO) ...

Use of ultra-short-acting β-blockers (esmolol or landiolol) for persistent tachycardia in patients with sepsis may not reduce mortality.

Gefapixant decreased cough-induced stress urinary incontinence (CSUI) episodes in women with refractory/unexplained chronic cough and CSUI.

Positive airway pressure (PAP) utilization is associated with lower all-cause mortality and major adverse cardiovascular event (MACE) incidence in older adults with obstructive sleep apnea (OSA), ...

A new single-dose autoinjector presentation of Adbry is now available for use in the treatment of moderate to severe atopic dermatitis.

The FDA has approved Fasenra® (benralizumab) for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis.

The route of abatacept administration does not appear to impact its efficacy when treating rheumatoid arthritis-associated interstitial lung disease. The route of abatacept (ABA) administration does ...

In pediatric sepsis, illness severity, immunocompromised status, invasive procedures, and infection site are all linked to secondary and/or prolonged infection. Lymphopenia is an independent risk ...